{"id":7953,"date":"2025-07-26T08:34:28","date_gmt":"2025-07-26T06:34:28","guid":{"rendered":"https:\/\/expandlabs.ro\/?page_id=7953"},"modified":"2025-08-29T17:17:08","modified_gmt":"2025-08-29T15:17:08","slug":"cancertrack","status":"publish","type":"page","link":"https:\/\/expandlabs.ro\/en\/cancertrack\/","title":{"rendered":"CANCERTRACK"},"content":{"rendered":"
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

cancertrack<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

CancerTrack este un test revolu\u021bionar pentru monitorizarea evolu\u021biei cancerului \u00een timp real prin analiza ADN-ului tumoral circulant.<\/p><\/div><\/div><\/div><\/div>

\u00a0<\/div><\/div><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tBook now<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

About Test<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
  • Test de tip\u00a0biopsie lichid\u0103<\/strong>, realizat printr-o simpl\u0103 recoltare de s\u00e2nge.<\/li>
  • Monitorizeaz\u0103 \u00een timp real\u00a0prezen\u021ba \u0219i evolu\u021bia celulelor tumorale circulante (CTC-uri)<\/strong>\u00a0\u0219i a ADN-ului tumoral liber (ctDNA).<\/li>
  • Permite o evaluare\u00a0non-invaziv\u0103, repetabil\u0103<\/strong>\u00a0a dinamicii bolii.<\/li>
  • Poate detecta\u00a0recidiva sau progresia tumorii<\/strong>\u00a0\u00eenainte ca acestea s\u0103 fie vizibile imagistic.<\/li>
  • Util pentru a evalua\u00a0eficien\u021ba tratamentului oncologic<\/strong>\u00a0\u0219i a adapta terapia la timp.<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
    \n\t\t
    \n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t

    Who is it for?<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t
    • Persoane care au terminat tratamentul \u0219i au nevoie de\u00a0monitorizare constant\u0103 a riscului de recidiv\u0103<\/strong>.<\/li>
    • Pacien\u021bi pentru care este important\u0103\u00a0urm\u0103rirea r\u0103spunsului la terapie<\/strong>\u00a0\u0219i ajustarea rapid\u0103 a acesteia.<\/li>
    • Cazuri unde metodele imagistice (CT, RMN, PET-CT) nu arat\u0103 \u00eenc\u0103 modific\u0103ri, dar medicul dore\u0219te informa\u021bii biologice timpurii despre progresia bolii.<\/li>
    • Pacien\u021bi care doresc o metod\u0103\u00a0minim invaziv\u0103 \u0219i repetabil\u0103<\/strong>\u00a0pentru urm\u0103rirea evolu\u021biei cancerului.<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
      \n\t\t\t\t\t
      \n\t\t\t\t
      \n\t\t\t\t
      \n\t\t\t\t\t\t\t
      \n\t\t\t
      <\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
      \n\t\t\t\t\t
      \n\t\t
      \n\t\t
      \n\t\t\t\t
      \n\t\t\t\t
      \n\t\t\t\t\t

      Avantajele testului Cancertrack<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
      \n\t\t\t\t
      \n\t\t\t\t\t\t\t\t\t

      • Test non-invaziv<\/strong>, sigur, precis, simplu \u0219i rentabil.<\/p><\/li>

      • Nu depinde<\/strong> de disponibilitatea \u021besutului tumoral.<\/p><\/li>

      • Offer mai multe informa\u021bii dec\u00e2t biopsia standard<\/strong> \u0219i analiza histopatologic\u0103 (HPE) la diagnostic.<\/p><\/li>

      • Acoperire extins\u0103 a biomarkerilor recomanda\u021bi de NCCN<\/strong>.<\/p><\/li>

      • Neafectat de heterogenitatea tumorii<\/strong>, oferind rezultate consistente.<\/p><\/li>

      • Offer informa\u021bii relevante \u0219i actualizate despre starea tumorii<\/strong> \u00een timp real.<\/p><\/li>

      • Poate fi efectuat oric\u00e2t de des este necesar<\/strong>, f\u0103r\u0103 disconfort major pentru pacient.<\/p><\/li>

      • Test ultra-sensibil, precis \u0219i fiabil<\/strong>, optim pentru ghidarea deciziilor terapeutice.<\/p><\/li>

      • Permite monitorizarea progresului tratamentului \u0219i a r\u0103spunsului tumorii<\/strong> \u00een timp real, facilit\u00e2nd ajustarea rapid\u0103 a terapiei pentru rezultate optime.<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
        \n\t\t
        \n\t\t\t\t
        \n\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"Expand\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
        \n\t\t\t\t\t
        \n\t\t
        \n\t\t
        \n\t\t\t\t
        \n\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"circulating\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
        \n\t\t
        \n\t\t\t\t
        \n\t\t\t\t
        \n\t\t\t\t\t

        Cum func\u021bioneaz\u0103?\u200b<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
        \n\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t
        • Dintr-o\u00a0prob\u0103 simpl\u0103 de s\u00e2nge<\/strong>\u00a0sunt analizate\u00a0circulating tumor cells (CTCs)<\/strong>\u00a0and\u00a0ADN-ul tumoral circulant (ctDNA)<\/strong>.<\/li>
        • Tehnologia detecteaz\u0103 \u0219i cuantific\u0103\u00a0num\u0103rul de CTC-uri<\/strong>\u00a0\u0219i modific\u0103rile moleculare asociate cancerului.<\/li>
        • Rezultatele arat\u0103\u00a0tendin\u021ba bolii<\/strong>: dac\u0103 celulele tumorale scad (tratamentul func\u021bioneaz\u0103) sau cresc (boala progreseaz\u0103).<\/li>
        • Modific\u0103rile pot fi eviden\u021biate\u00a0mult mai devreme<\/strong>\u00a0dec\u00e2t prin imagistica clasic\u0103 (CT, RMN, PET).<\/li>
        • Prin repetarea testului la intervale regulate, medicul poate urm\u0103ri\u00a0evolu\u021bia \u00een timp<\/strong>\u00a0\u0219i poate adapta rapid strategia de tratament.<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
          \n\t\t\t\t\t
          \n\t\t
          \n\t\t\t\t\t
          \n\t\t
          \n\t\t\t\t
          \n\t\t\t\t
          \n\t\t\t\t\t

          Variante disponibile\u200b\n<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
          \n\t\t\t\t
          \n\t\t\t\t\t\t\t\t\t

          CancerTrack vine \u00een mai multe op\u021biuni, \u00een func\u021bie de necesit\u0103\u021bile clinice:<\/strong><\/p>

          • Standard<\/strong>\u00a0\u2192 monitorizare simpl\u0103 a CTC-urilor (progresie vs r\u0103spuns).<\/li>
          • Plus<\/strong>\u00a0\u2192 monitorizare + muta\u021bii genetice cu rol terapeutic.<\/li>
          • Comprehensive<\/strong>\u00a0\u2192 evaluare complet\u0103 \u0219i detaliat\u0103 a dinamicii \u0219i a profilului molecular.<\/li><\/ul><\/div><\/div><\/div><\/div><\/div><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
            \n\t\t\t\t\t
            \n\t\t\t\t
            \n\t\t\t\t
            \n\t\t\t\t\t


            Metoda CancerTrack
            \n<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
            \n\t\t\t\t
            \n\t\t\t\t
            \n\t\t\t\t\t\t\t\t\t

            Metodele conven\u021bionale de evaluare a stadiului cancerului \u0219i a r\u0103spunsului la tratament se bazeaz\u0103 pe scan\u0103ri radiologice la intervale de aproximativ 3 luni<\/strong>, care implic\u0103 expunere la radia\u021bii<\/strong> \u0219i necesit\u0103 vizite la centre medicale specializate. \u00cen plus, aceste metode nu pot anticipa e\u0219ecul terapiei sau progresia bolii<\/strong>.<\/p>

            De\u0219i antigenele tumorale serice<\/strong> au fost utilizate pentru unele tipuri de cancer, ele prezint\u0103 acurate\u021be mai redus\u0103<\/strong> \u00een predic\u021bia progresiei bolii \u0219i nu ofer\u0103 informa\u021bii despre mecanismele moleculare<\/strong> care stau la baza acesteia.<\/p>

            Un liquid biopsy inteligent<\/strong>, care furnizeaz\u0103 informa\u021bii relevante despre stadiul cancerului, inclusiv semne timpurii ale progresiei bolii<\/strong> and mecanismele moleculare asociate<\/strong>, poate facilita decizii clinice mai eficiente<\/strong>, conduc\u00e2nd la management optimizat \u0219i rezultate mai bune pentru pacient<\/strong>.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

            \n\t\t\t\t
            \n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"Expand\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
            \n\t\t\t\t
            \n\t\t\t\t\t\t\t\t\t

            Cancertrack\u2122<\/strong> analizeaz\u0103 analyte tumorale circulante<\/strong> \u2013 ADN, ARN \u0219i CTC-uri \u2013 prezente \u00een mod constant \u00een s\u00e2ngele pacien\u021bilor cu tumori solide. Studii clinice multiple, inclusiv cele efectuate de DCG, au demonstrat c\u0103 liquid biopsies permit decizii clinice mai eficiente \u0219i management superior al cancerului<\/strong>, contribuind la \u00eembun\u0103t\u0103\u021birea rezultatelor pacientului<\/strong>. Principiile \u0219tiin\u021bifice ale Cancertrack\u2122<\/strong> sunt bine stabilite, iar testul a fost validat conform standardelor interna\u021bionale stricte<\/strong>.<\/p>

            Timp de procesare<\/h5>

            De regul\u0103, testul \u0219i analiza sunt finalizate \u00een 10 zile<\/strong>, iar raportul final este emis \u00een maxim 12 zile<\/strong> de la primirea probei la laboratorul nostru.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

            \n\t\t\t\t\t
            \n\t\t\t\t
            \n\t\t\t\t
            \n\t\t\t\t\t


            FAQ<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
            \n\t\t\t\t
            \n\t\t\t\t\t\t\t
            \n\t\t\t\t\t\t
            \n\t\t\t\t\n\t\t\t\t\t
            De ce este esen\u021bial\u0103 detectarea timpurie a dinamicii moleculare a cancerului? <\/div><\/span>\n\t\t\t\t\t\t\t\n\t\t\t<\/path><\/svg><\/span>\n\t\t\t<\/path><\/svg><\/span>\n\t\t<\/span>\n\n\t\t\t\t\t\t<\/summary>\n\t\t\t\t
            \n\t\t\t\t
            \n\t\t\t\t
            \n\t\t\t\t\t\t\t\t\t

            Evolu\u021bia molecular\u0103 a tumorii \u2013 inclusiv cre\u0219terea \u00een dimensiune \u0219i diversificarea molecular\u0103 \u2013 este un proces continuu, care poate avansa rapid. Prin urmare, detectarea precoce a recidivei sau a rezisten\u021bei la tratament<\/strong> este esen\u021bial\u0103 pentru a men\u021bine cancerul sub control.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/details>\n\t\t\t\t\t\t

            \n\t\t\t\t\n\t\t\t\t\t
            C\u00e2t de frecvent trebuie efectuat testul? <\/div><\/span>\n\t\t\t\t\t\t\t\n\t\t\t<\/path><\/svg><\/span>\n\t\t\t<\/path><\/svg><\/span>\n\t\t<\/span>\n\n\t\t\t\t\t\t<\/summary>\n\t\t\t\t
            \n\t\t\t\t
            \n\t\t\t\t
            \n\t\t\t\t\t\t\t\t\t

            CancerTrack<\/strong> ar trebui ideal efectuat la fiecare etap\u0103 important\u0103<\/strong> din parcursul tratamentului oncologic \u0219i mai ales \u00een situa\u021biile \u00een care tumora nu mai este vizibil\u0103 pe imagistica conven\u021bional\u0103<\/strong>, iar pacientul se afl\u0103 \u00een monitorizare pentru depistarea recidivei<\/strong>. \u00cen general, testarea se face la fiecare 3 \u2013 12 luni<\/strong>.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/details>\n\t\t\t\t\t\t

            \n\t\t\t\t\n\t\t\t\t\t
            Prelevarea probei \u0219i timpul de r\u0103spuns (TAT) <\/div><\/span>\n\t\t\t\t\t\t\t\n\t\t\t<\/path><\/svg><\/span>\n\t\t\t<\/path><\/svg><\/span>\n\t\t<\/span>\n\n\t\t\t\t\t\t<\/summary>\n\t\t\t\t
            \n\t\t\t\t
            \n\t\t\t\t
            \n\t\t\t\t\t\t\t\t\t

            • Volum de s\u00e2nge necesar<\/strong>: 40 ml, recoltat \u00een tuburi DCGL \u0219i EDTA<\/p><\/li>

            • Timp de r\u0103spuns<\/strong>: 8 \u2013 10 zile lucr\u0103toare de la primirea probei \u00een laborator<\/p><\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/details>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"

              cancertrack CancerTrack este un test revolu\u021bionar pentru monitorizarea evolu\u021biei cancerului \u00een timp real prin analiza ADN-ului tumoral circulant. \u00a0 Rezerv\u0103 acum Despre Test Test de tip\u00a0biopsie lichid\u0103, realizat printr-o simpl\u0103 recoltare de s\u00e2nge. Monitorizeaz\u0103 \u00een timp real\u00a0prezen\u021ba \u0219i evolu\u021bia celulelor tumorale circulante (CTC-uri)\u00a0\u0219i a ADN-ului tumoral liber (ctDNA). Permite o evaluare\u00a0non-invaziv\u0103, repetabil\u0103\u00a0a dinamicii bolii. Poate detecta\u00a0recidiva sau progresia tumorii\u00a0\u00eenainte ca acestea s\u0103 fie vizibile imagistic. Util pentru a evalua\u00a0eficien\u021ba tratamentului oncologic\u00a0\u0219i a adapta terapia la timp. Pentru cine este? Persoane care au terminat tratamentul \u0219i au nevoie de\u00a0monitorizare constant\u0103 a riscului de recidiv\u0103. Pacien\u021bi pentru care este important\u0103\u00a0urm\u0103rirea r\u0103spunsului la terapie\u00a0\u0219i ajustarea rapid\u0103 a acesteia. Cazuri unde metodele imagistice (CT, RMN, PET-CT) nu arat\u0103 \u00eenc\u0103 modific\u0103ri, dar medicul dore\u0219te informa\u021bii biologice timpurii despre progresia bolii. Pacien\u021bi care doresc o metod\u0103\u00a0minim invaziv\u0103 \u0219i repetabil\u0103\u00a0pentru urm\u0103rirea evolu\u021biei cancerului. Avantajele testului Cancertrack Test non-invaziv, sigur, precis, simplu \u0219i rentabil. Nu depinde de disponibilitatea \u021besutului tumoral. Ofer\u0103 mai multe informa\u021bii dec\u00e2t biopsia standard \u0219i analiza histopatologic\u0103 (HPE) la diagnostic. Acoperire extins\u0103 a biomarkerilor recomanda\u021bi de NCCN. Neafectat de heterogenitatea tumorii, oferind rezultate consistente. Ofer\u0103 informa\u021bii relevante \u0219i actualizate despre starea tumorii \u00een timp real. Poate fi efectuat oric\u00e2t de des este necesar, f\u0103r\u0103 disconfort major pentru pacient. Test ultra-sensibil, precis \u0219i fiabil, optim pentru ghidarea deciziilor terapeutice. Permite monitorizarea progresului tratamentului \u0219i a r\u0103spunsului tumorii \u00een timp real, facilit\u00e2nd ajustarea rapid\u0103 a terapiei pentru rezultate optime. Cum func\u021bioneaz\u0103?\u200b Dintr-o\u00a0prob\u0103 simpl\u0103 de s\u00e2nge\u00a0sunt analizate\u00a0celulele tumorale circulante (CTC-uri)\u00a0\u0219i\u00a0ADN-ul tumoral circulant (ctDNA). Tehnologia detecteaz\u0103 \u0219i cuantific\u0103\u00a0num\u0103rul de CTC-uri\u00a0\u0219i modific\u0103rile moleculare asociate cancerului. Rezultatele arat\u0103\u00a0tendin\u021ba bolii: dac\u0103 celulele tumorale scad (tratamentul func\u021bioneaz\u0103) sau cresc (boala progreseaz\u0103). Modific\u0103rile pot fi eviden\u021biate\u00a0mult mai devreme\u00a0dec\u00e2t prin imagistica clasic\u0103 (CT, RMN, PET). Prin repetarea testului la intervale regulate, medicul poate urm\u0103ri\u00a0evolu\u021bia \u00een timp\u00a0\u0219i poate adapta rapid strategia de tratament. Variante disponibile\u200b CancerTrack vine \u00een mai multe op\u021biuni, \u00een func\u021bie de necesit\u0103\u021bile clinice: Standard\u00a0\u2192 monitorizare simpl\u0103 a CTC-urilor (progresie vs r\u0103spuns). Plus\u00a0\u2192 monitorizare + muta\u021bii genetice cu rol terapeutic. Comprehensive\u00a0\u2192 evaluare complet\u0103 \u0219i detaliat\u0103 a dinamicii \u0219i a profilului molecular. Metoda CancerTrack Metodele conven\u021bionale de evaluare a stadiului cancerului \u0219i a r\u0103spunsului la tratament se bazeaz\u0103 pe scan\u0103ri radiologice la intervale de aproximativ 3 luni, care implic\u0103 expunere la radia\u021bii \u0219i necesit\u0103 vizite la centre medicale specializate. \u00cen plus, aceste metode nu pot anticipa e\u0219ecul terapiei sau progresia bolii. De\u0219i antigenele tumorale serice au fost utilizate pentru unele tipuri de cancer, ele prezint\u0103 acurate\u021be mai redus\u0103 \u00een predic\u021bia progresiei bolii \u0219i nu ofer\u0103 informa\u021bii despre mecanismele moleculare care stau la baza acesteia. Un liquid biopsy inteligent, care furnizeaz\u0103 informa\u021bii relevante despre stadiul cancerului, inclusiv semne timpurii ale progresiei bolii \u0219i mecanismele moleculare asociate, poate facilita decizii clinice mai eficiente, conduc\u00e2nd la management optimizat \u0219i rezultate mai bune pentru pacient. Cancertrack\u2122 analizeaz\u0103 analyte tumorale circulante \u2013 ADN, ARN \u0219i CTC-uri \u2013 prezente \u00een mod constant \u00een s\u00e2ngele pacien\u021bilor cu tumori solide. Studii clinice multiple, inclusiv cele efectuate de DCG, au demonstrat c\u0103 liquid biopsies permit decizii clinice mai eficiente \u0219i management superior al cancerului, contribuind la \u00eembun\u0103t\u0103\u021birea rezultatelor pacientului. Principiile \u0219tiin\u021bifice ale Cancertrack\u2122 sunt bine stabilite, iar testul a fost validat conform standardelor interna\u021bionale stricte. Timp de procesare De regul\u0103, testul \u0219i analiza sunt finalizate \u00een 10 zile, iar raportul final este emis \u00een maxim 12 zile de la primirea probei la laboratorul nostru. FAQ De ce este esen\u021bial\u0103 detectarea timpurie a dinamicii moleculare a cancerului? Evolu\u021bia molecular\u0103 a tumorii \u2013 inclusiv cre\u0219terea \u00een dimensiune \u0219i diversificarea molecular\u0103 \u2013 este un proces continuu, care poate avansa rapid. Prin urmare, detectarea precoce a recidivei sau a rezisten\u021bei la tratament este esen\u021bial\u0103 pentru a men\u021bine cancerul sub control. C\u00e2t de frecvent trebuie efectuat testul? CancerTrack ar trebui ideal efectuat la fiecare etap\u0103 important\u0103 din parcursul tratamentului oncologic \u0219i mai ales \u00een situa\u021biile \u00een care tumora nu mai este vizibil\u0103 pe imagistica conven\u021bional\u0103, iar pacientul se afl\u0103 \u00een monitorizare pentru depistarea recidivei. \u00cen general, testarea se face la fiecare 3 \u2013 12 luni. Prelevarea probei \u0219i timpul de r\u0103spuns (TAT) Volum de s\u00e2nge necesar: 40 ml, recoltat \u00een tuburi DCGL \u0219i EDTA Timp de r\u0103spuns: 8 \u2013 10 zile lucr\u0103toare de la primirea probei \u00een laborator Evolu\u021bia molecular\u0103 a tumorii \u2013 inclusiv cre\u0219terea \u00een dimensiune \u0219i diversificarea molecular\u0103 \u2013 este un proces continuu, care poate avansa rapid. Prin urmare, detectarea precoce a recidivei sau a rezisten\u021bei la tratament este esen\u021bial\u0103 pentru a men\u021bine cancerul sub control. CancerTrack ar trebui ideal efectuat la fiecare etap\u0103 important\u0103 din parcursul tratamentului oncologic \u0219i mai ales \u00een situa\u021biile \u00een care tumora nu mai este vizibil\u0103 pe imagistica conven\u021bional\u0103, iar pacientul se afl\u0103 \u00een monitorizare pentru depistarea recidivei. \u00cen general, testarea se face la fiecare 3 \u2013 12 luni. Volum de s\u00e2nge necesar: 40 ml, recoltat \u00een tuburi DCGL \u0219i EDTA Timp de r\u0103spuns: 8 \u2013 10 zile lucr\u0103toare de la primirea probei \u00een laborator<\/p>","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-7953","page","type-page","status-publish","hentry"],"blocksy_meta":[],"acf":[],"_links":{"self":[{"href":"https:\/\/expandlabs.ro\/en\/wp-json\/wp\/v2\/pages\/7953","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/expandlabs.ro\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/expandlabs.ro\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/expandlabs.ro\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/expandlabs.ro\/en\/wp-json\/wp\/v2\/comments?post=7953"}],"version-history":[{"count":45,"href":"https:\/\/expandlabs.ro\/en\/wp-json\/wp\/v2\/pages\/7953\/revisions"}],"predecessor-version":[{"id":9030,"href":"https:\/\/expandlabs.ro\/en\/wp-json\/wp\/v2\/pages\/7953\/revisions\/9030"}],"wp:attachment":[{"href":"https:\/\/expandlabs.ro\/en\/wp-json\/wp\/v2\/media?parent=7953"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}